Wednesday, 16 August 2017

Generics News

  • Interpol seized $41 mn fake drugs to be sold online

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2013

    Singapore: Interpol's sixth and the biggest annual worldwide crackdown, Pangea VI has ended in seizing of $41 million worth of illegal pharmaceuticals that were being sold online. The worl...Read more

  • India, China to produce generic of Gilead's TAF

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2014

    Singapore: Gilead have allowed generic manufacturers in India and China to produce generic versions of its HBV and HIV drug, tenofovir alafenamide (TAF). The company is in agreement with t...Read more

  • Indian formulation industry to grow by 10-12%

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013

    Singapore: The Indian pharmaceutical industry is estimated to continue to experience strong growth in the near-term although there would be some moderation in the growth trajectory, a repor...Read more

  • Dr. Reddy's hires its HR global head from IBM

    Generics |  Influencers | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2013

    Singapore: India's pharmaceutical firm Dr. Reddy's has appointed Dr. Sripada Chandrasekhar as the president and global head of human resources. He will also be a member of Dr. Reddy's Manag...Read more

  • Huahai gets China FDA nod to make HIV/AIDS generic

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2013

    Singapore: China-based Zhejiang Huahai Pharma received approval from the China FDA to produce efavirenz. Huahai is the first Chinese drugmaker to receive approval to make the drug. The dru...Read more

  • US firms lobbying to protect patents in India: Report

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 24 Oct, 2013

    Singapore: An Indian news report that appeared in Business Line quoted an unidentified DIPP official who claimed that top officials of many US pharmaceutical companies recently met the Depa...Read more

  • Merck aims to expand its China business

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2014

    Singapore: Leading pharma giant Merck has reinforced its commitments towards China, in a bid to strengthen its position among emerging markets. Merck aims to construct its pioneering new ph...Read more

  • Blogger sued by pharma firm for the first time in India

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012

    Mumbai: NATCO Pharma has filed a lawsuit against Mr Shamnaad Basheer, professor, West Bengal National University of Juridical Sciences, Kolkata, over his alleged defamatory remarks publishe...Read more

  • Actavis sets up APAC headquarter in Singapore

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Apr, 2014

    Singapore: Global generics firm, Actavis, has opened its regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region. In addit...Read more

  • Indian regulator cracks down on banned drugs

    Generics |  News | By Narayanan Suresh | 0 Comment | 21 Jan, 2013

    Bangalore: As a first step to prevent misuse of drugs, which have been banned abroad from being sold freely in the country, Drug Controller General of India (DGCI) has directed all companie...Read more

  • Why Mylan sued US FDA over Diovan generic?

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012

    Multinational pharmaceutical company Mylan sued the US Food and Drug Administration (FDA) for approval to sell a generic version of Novartis' blockbuster anti-hypertensive drug Diovan (vals...Read more

  • Ranbaxy now recalls 64,000 bottles of generic heart drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2014

    Singapore: Ranbaxy Laboratories, which is already reeling under several regulatory rebukes owing to quality apprehensions, recalled more than 64,000 bottles containing tablets of atorvastat...Read more

  • APAC Epilepsy Therapeutics market to touch $1.5 bn by 2019

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2014

    Singapore: The epilepsy therapeutics market value in the Asia-Pacific (APAC) region, Australia, China, India and Japan, is expected to increase moderately, climbing from USD1.1 billion in 2...Read more

  • Pfizer, Mylan settle litigation over Detrol LA generic

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012

    Singapore: Pfizer has settled its litigation against Mylan and Mylan Pharmaceuticals relating to Pfizer's patents covering Detrol LA (tolterodine tartrate) extended-release capsules. The p...Read more

  • Mundipharma, Horizon subsidiary sign arthritis deal

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2013

    Singapore: Mundipharma has signed an exclusive agreement with the Swiss subsidiary of Horizon Pharma for the commercialization and distribution of Lodotra in the Middle East and African reg...Read more

  • Aurobindo diabetes generic gets US FDA nod

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2014

    Singapore: Aurobindo Pharma has received US FDA approval for Repaglinide tablets, the generic equivalent of Novo Nordisk's Prandin Tablets. The drug is indicated as an adjunct to diet and...Read more

  • Patents worth $60 billion set to expire by 2019

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012

    The year 2012 has brought a world of opportunities for Indian biotech companies, with big-wig biotech firms in the West facing a spree of patent expiration of their blockbuster products. Gr...Read more

  • Cipla nurtures global vision for affordable drugs

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2012

    The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market. Without missing any opportunity to serve the healthcare industry in...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls